Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer

Author： Salatino Mariana Croci Diego O Bianco Germán A Ilarregui Juan M Toscano Marta A Rabinovich Gabriel A

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.8, Iss.1, 2008-01, pp. : 45-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions

By Bombardieri Michele McInnes Iain B Pitzalis Costantino

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 31-40

Informa Healthcare

Access to resources Recommend Favorite

Galectin-3 in apoptosis, a novel therapeutic target

By Nangia-Makker Pratima Nakahara Susumu Hogan Victor Raz Avraham

Journal of Bioenergetics and Biomembranes, Vol. 39, Iss. 1, 2007-02 ,pp. : 79-84

Springer Publishing Company

Access to resources Recommend Favorite

Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis

By Hu Peng-fei Chen Yi Cai Peng-fei Jiang Li-feng Wu Li-dong

Molecular Biology Reports, Vol. 38, Iss. 6, 2011-08 ,pp. : 4225-4230

Springer Publishing Company

Access to resources Recommend Favorite

11&bgr;-Hydroxysteroid Dehydrogenase Type 1: A Potential Therapeutic Target for the Control of Local Glucocorticoid Concentrations

Current Enzyme Inhibition, Vol. 1, Iss. 2, 2005-06 ,pp. : 107-122

Bentham Science Publishers

Access to resources Recommend Favorite

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J Lui Vivian Wai Yan Grandis Jennifer Rubin

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite